These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30054821)

  • 1. Intraoperative Pathologic Evaluation with Targeted Axillary Dissection : Editorial for "Intraoperative Touch Imprint Cytology in Targeted Axillary Dissection After Neoadjuvant Chemotherapy Among Breast Cancer Patients with Initial Axillary Metastasis".
    Caudle AS
    Ann Surg Oncol; 2018 Oct; 25(11):3112-3114. PubMed ID: 30054821
    [No Abstract]   [Full Text] [Related]  

  • 2. The problem of axillary staging in breast cancer after neoadjuvant chemotherapy. Role of targeted axillary dissection and types of lymph node markers.
    Flores-Funes D; Aguilar-Jiménez J; Martínez-Gálvez M; Ibáñez-Ibáñez MJ; Carrasco-González L; Gil-Izquierdo JI; Aguayo-Albasini JL
    Cir Esp (Engl Ed); 2020 Nov; 98(9):510-515. PubMed ID: 32386728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraoperative sentinel node biopsy by one-step nucleic acid amplification (OSNA) avoids axillary lymphadenectomy in women with breast cancer treated with neoadjuvant chemotherapy.
    Navarro-Cecilia J; Dueñas-Rodríguez B; Luque-López C; Ramírez-Expósito MJ; Martínez-Ferrol J; Ruíz-Mateas A; Ureña C; Carrera-González MP; Mayas MD; Martínez-Martos JM
    Eur J Surg Oncol; 2013 Aug; 39(8):873-9. PubMed ID: 23711734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraoperative imprint cytology examination of sentinel lymph nodes after neoadjuvant chemotherapy in breast cancer patients.
    Gimbergues P; Dauplat MM; Durando X; Abrial C; Le Bouedec G; Mouret-Reynier MA; Cachin F; Kwiatkowski F; Tchirkov A; Dauplat J; Penault-Llorca F
    Ann Surg Oncol; 2010 Aug; 17(8):2132-7. PubMed ID: 20155400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentinel node biopsy before neoadjuvant chemotherapy spares breast cancer patients axillary lymph node dissection.
    van Rijk MC; Nieweg OE; Rutgers EJ; Oldenburg HS; Olmos RV; Hoefnagel CA; Kroon BB
    Ann Surg Oncol; 2006 Apr; 13(4):475-9. PubMed ID: 16485148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of axillary sampling in the era of sentinel lymph node biopsy: a critical review.
    Bassi KK; Seenu V; Srivastava A; Al Sharara N
    Indian J Cancer; 2012; 49(1):66-73. PubMed ID: 22842171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraoperative assessment of sentinel lymph node by one-step nucleic acid amplification in breast cancer patients after neoadjuvant treatment reduces the need for a second surgery for axillary lymph node dissection.
    Espinosa-Bravo M; Navarro-Cecilia J; Ramos Boyero M; Diaz-Botero S; Dueñas Rodríguez B; Luque López C; Ramos Grande T; Ruano Perez R; Peg V; Rubio IT
    Breast; 2017 Feb; 31():40-45. PubMed ID: 27810698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraoperative touch imprint and frozen section analysis of sentinel lymph nodes after neoadjuvant chemotherapy for breast cancer.
    Komenaka IK; Torabi R; Nair G; Jayaram L; Hsu CH; Bouton ME; Dave H; Hobohm D
    Ann Surg; 2010 Feb; 251(2):319-22. PubMed ID: 19864940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sentinel lymph node biopsy after neoadjuvant treatment in breast cancer: Work in progress.
    Rubio IT
    Eur J Surg Oncol; 2016 Mar; 42(3):326-32. PubMed ID: 26774943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower nodal counts in axillary dissection following neoadjuvant chemotherapy: are there implications?
    Callcut RA; Breslin TM
    Am J Surg; 2006 Jun; 191(6):830-1. PubMed ID: 16720160
    [No Abstract]   [Full Text] [Related]  

  • 11. Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patients With an Initial Diagnosis of Cytology-Proven Lymph Node-Positive Breast Cancer.
    Enokido K; Watanabe C; Nakamura S; Ogiya A; Osako T; Akiyama F; Yoshimura A; Iwata H; Ohno S; Kojima Y; Tsugawa K; Motomura K; Hayashi N; Yamauchi H; Sato N
    Clin Breast Cancer; 2016 Aug; 16(4):299-304. PubMed ID: 26993216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of intraoperative touch imprint cytology of sentinel lymph node for breast cancer].
    Huang XY; Wu J; Xu WP; Wang LF; Shi DR; Zhou M; Zhang JX; Han QX; Shen KW; Shen ZZ; Shao ZM
    Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):596-9. PubMed ID: 18210879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is OSNA better than imprint cytology for intraoperative diagnosis of cancer involvement of axillary sentinel node in breast cancer?
    Luna-Tomás MA; Solà-Suárez M; Mariscal-Martínez A; Castellà-Fernández E; Martínez-Román S; Pascual-Miguel I; Quiroga-García V; Julián-Ibáñez JF
    Breast; 2018 Apr; 38():181-187. PubMed ID: 29455041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection.
    Caudle AS; Yang WT; Krishnamurthy S; Mittendorf EA; Black DM; Gilcrease MZ; Bedrosian I; Hobbs BP; DeSnyder SM; Hwang RF; Adrada BE; Shaitelman SF; Chavez-MacGregor M; Smith BD; Candelaria RP; Babiera GV; Dogan BE; Santiago L; Hunt KK; Kuerer HM
    J Clin Oncol; 2016 Apr; 34(10):1072-8. PubMed ID: 26811528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel Node Lymph Node Surgery After Neoadjuvant Therapy: Principles and Techniques.
    Racz JM; Caudle AS
    Ann Surg Oncol; 2019 Oct; 26(10):3040-3045. PubMed ID: 31342394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Touch preparations for the intraoperative evaluation of sentinel lymph nodes after neoadjuvant therapy have high false-negative rates in patients with breast cancer.
    Elliott RM; Shenk RR; Thompson CL; Gilmore HL
    Arch Pathol Lab Med; 2014 Jun; 138(6):814-8. PubMed ID: 24878021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sentinel lymph node biopsy and neoadjuvant treatment in breast cancer].
    Duraes M; Guillot E; Seror J; Pouget N; Rouzier R
    Bull Cancer; 2017 Oct; 104(10):892-901. PubMed ID: 28890124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Axillary sentinel lymph node biopsy after neoadjuvant chemotherapy for carcinoma of the breast.
    Schwartz GF; Tannebaum JE; Jernigan AM; Palazzo JP
    Cancer; 2010 Mar; 116(5):1243-51. PubMed ID: 20087958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome following sentinel lymph node biopsy-guided decisions in breast cancer patients with conversion from positive to negative axillary lymph nodes after neoadjuvant chemotherapy.
    Kang YJ; Han W; Park S; You JY; Yi HW; Park S; Nam S; Kim JH; Yun KW; Kim HJ; Ahn SH; Park S; Lee JE; Lee ES; Noh DY; Lee JW
    Breast Cancer Res Treat; 2017 Nov; 166(2):473-480. PubMed ID: 28766131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel node biopsy after neoadjuvant treatment in breast cancer: Five-year follow-up of patients with clinically node-negative or node-positive disease before treatment.
    Galimberti V; Ribeiro Fontana SK; Maisonneuve P; Steccanella F; Vento AR; Intra M; Naninato P; Caldarella P; Iorfida M; Colleoni M; Viale G; Grana CM; Rotmensz N; Luini A
    Eur J Surg Oncol; 2016 Mar; 42(3):361-8. PubMed ID: 26746091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.